Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Lavin

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
JAMA|April 3, 1991
Placebo effects on mind and bodyM R Lavin
Depression and Anxiety|January 1, 1996
Misuse of loperamide in anxiety disorder patientsM R Lavin
The American Journal of Psychiatry|December 1, 1992
Patients' appearance and psychopathologyM R Lavin
The American Journal of Psychiatry|December 1, 1992
A second look at the placebo responseM R Lavin
The American Journal of Psychiatry|November 1, 1993
Neuroleptic-induced extrapyramidal side effectsM R Lavin
The American Journal of Psychiatry|November 1, 1991
Psychotic patients' interpretation of neuroleptic side effectsM R Lavin, A Rifkin
Journal of Clinical Pharmacology|August 1, 1991
Prophylactic antiparkinson drug use: I. Initial prophylaxis and prevention of extrapyramidal side effectsM R Lavin, A Rifkin
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 1, 1993
Diagnosis and pharmacotherapy of conduct disorderM R Lavin, A Rifkin
The American Journal of Psychiatry|December 1, 1996
ECT for comorbid obsessive-compulsive disorder and schizophreniaM R Lavin, P Halligan
Journal of Clinical Pharmacology|August 1, 1991
Prophylactic antiparkinson drug use: II. Withdrawal after long-term maintenance therapyM R Lavin, A Rifkin
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
JAMA|April 3, 1991
Placebo effects on mind and bodyM R Lavin
Depression and Anxiety|January 1, 1996
Misuse of loperamide in anxiety disorder patientsM R Lavin
The American Journal of Psychiatry|December 1, 1992
Patients' appearance and psychopathologyM R Lavin
The American Journal of Psychiatry|December 1, 1992
A second look at the placebo responseM R Lavin
The American Journal of Psychiatry|November 1, 1993
Neuroleptic-induced extrapyramidal side effectsM R Lavin
The American Journal of Psychiatry|November 1, 1991
Psychotic patients' interpretation of neuroleptic side effectsM R Lavin, A Rifkin
Journal of Clinical Pharmacology|August 1, 1991
Prophylactic antiparkinson drug use: I. Initial prophylaxis and prevention of extrapyramidal side effectsM R Lavin, A Rifkin
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 1, 1993
Diagnosis and pharmacotherapy of conduct disorderM R Lavin, A Rifkin
The American Journal of Psychiatry|December 1, 1996
ECT for comorbid obsessive-compulsive disorder and schizophreniaM R Lavin, P Halligan
Journal of Clinical Pharmacology|August 1, 1991
Prophylactic antiparkinson drug use: II. Withdrawal after long-term maintenance therapyM R Lavin, A Rifkin
Pageof 2